Hepatitis C Treatment Market to Register CAGR 3.9% Growth in Revenue During the Forecast Period 2024

Persistence Market Research (PMR) delivers key insights on the global hepatitis C treatment market in its latest report titled“Hepatitis C Treatment Market: Global Industry Analysis and Forecast, 2016–2024”.The globalhepatitis C treatment marketwasvalued at US$ 23.9 Bn in 2015and is estimated to be valued atUS$ 26.6 Bn by 2016. The market is expected to reach avaluation of US$ 71.13 Bnby the end of 2024, reflecting aCAGR of 13.1%over the forecast period.

Market dynamics

Growth of the global hepatitis C treatment market is primarily driven by factors such as increase in the prevalence of hepatitis C infections in the U.S. and Canada and rising per capita healthcare expenditure across the globe. Also government initiatives to control infection and various private NGOs creating awareness about treatment is also fueling the market growth.

Get Sample Copy of Report @https://www.persistencemarketresearch.com/samples/3602

Company Profiles

• Gilead Sciences, Inc.
• AbbVie Inc.
• Kadmon Holdings, Inc.
• F. Hoffmann-La Roche Ltd
• GlaxoSmithKline plc.
• Bristol-Myers Squibb Company
• Merck & Co., Inc.
• Johnson & Johnson

Get To Know Methodology of Report @https://www.persistencemarketresearch.com/methodology/3602

However, high cost associated with hepatitis C treatment drugs and lack of awareness about hepatitis C infection in the regions of Asia Pacific, Middle East and Africa, and Latin America is expected to impede growth of the global hepatitis C treatment market.

Market forecast

By drug class, the market is segmented into HCV Protease Inhibitors, HCV Polymerase Inhibitors, HCV NS5A Inhibitors, Combination Therapy and Interferon & Antiviral which is again sub-divided into various drugs sub segments. The combination segment is expected to contribute a maximum share to the global hepatitis C treatment market and register the fastestCAGR of 13.9%during the forecast period.

By distribution channel, the market is segmented into Hospital Pharmacies, Retail Pharmacies and Online Pharmacies. Among these, the hospital pharmacies segment is anticipated to be dominant throughout the forecast period and is projected to account for about 43.7% share of the total global hepatitis C treatment market revenue by 2024.

The hospital pharmacies segment is anticipated to emerge as the most attractive segment in the global hepatitis C treatment market owing to growing instances of hospitalization and improved accessibility and services. The online pharmacies segment is expected to register the fastest CAGR during the forecast period and is estimated to create absolute $ opportunity ofUS$ 713.8 Mnin 2017 over 2016.

Access Full Report @https://www.persistencemarketresearch.com/checkout/3602

The online pharmacies segment is expected to witness significant growth during the forecast period and this can be attributed to high availability of hepatitis C treatment drugs and discounts provided by online pharmacies.

This report covers global and regional trends along with an analysis of the market potential. North America is estimated to account for 45% share in the global hepatitis C treatment market by 2016, whereas Asia Pacific is projected to grow at a healthyCAGR of 14.8%due to increasing awareness about hepatitis C infections. Europe region is expected to account for 19.6% share in the global hepatitis C treatment market by 2016 end.

Latin America was valued atUS$ 2,915.8 Mn in 2015and is estimated to reachUS$ 3,311.1 Mn by 2016, with a Y-o-Y growth of 13.6% over 2015–2016. The Middle East and Africa region was valued at US$ 1,792.5 Mn in 2015 and is estimated to reach US$ 1,988.1 Mn by 2016.

Explore Extensive Coverage of PMR`sLife Sciences & Transformational HealthLandscape

Molecular Diagnostics Market –

Molecular Diagnostics MarketSegmentation by Key Players – Novartis AG, Roche Diagnostics, QIAGEN, Siemens Healthcare, Abbott Laboratories, Inc., Gen-Probe, Inc. (Hologic Inc.), Cepheid, Inc., Beckman Coulter, Inc., Becton, Dickinson & Company, Myriad Genetics, Inc., and bioMerieux.

Next-Generation Sequencing Market –

Next Generation Sequencing MarketSegmented by(By Application – Whole-genome Sequencing ,Exome Sequencing,Targeted Resequencing,De Novo Sequencing,RNA Sequencing,ChIP Sequencing,Methyl Sequencing,Others);By Technology- Targeted Sequencing & Resequencing,Whole Genome Sequencing,Whole Exome Sequencing.

Ophthalmology devises Market –

Ophthalmology devises MarketSegmentation by Key Players – Abbott Medical Optics Inc., Carl Zeiss Meditec AG, Bausch & Lomb Inc., Essilor International S.A, Ziemer Ophthalmic Systems AG and Topcon Corporation.

Intravenous Iron Drugs Market –

Intravenous (IV) Iron Drugs MarketSegmentation by Key Players- Actavis, Inc., AMAG Pharmaceuticals, Inc., Galenica Ltd., Fresenius Medical Care AG & Co. KGaA, Vifor Pharma Ltd., American Regent, Inc., Luitpold Pharmaceuticals, Inc., Pharmacosmos A/S, Rockwell Medical Technologies, Inc., and Sanofi.

Syndromes Progressive Ataxia Weakness Disorders Market –

Treatments forSyndromes of Progressive Ataxia and Weakness Disorders MarketSegmentation by Key Players- Abbott Laboratories, Acorda Therapeutics Inc., American Regent Inc., Baxter International Inc., Biogen Idec., Bristol-Myers Squibb, Cadila Healthcare Ltd., Eli Lilly and Company, Glaxosmilthkline Plc., Sanofi, Roche Holding Ltd., Pfizer Inc. and Novartis AG.

About us:

Persistence Market Research (PMR) is a third-platform research firm. Our research model is a unique collaboration of data analytics and market research methodology to help businesses achieve optimal performance.

To support companies in overcoming complex business challenges, we follow a multi-disciplinary approach. At PMR, we unite various data streams from multi-dimensional sources. By deploying real-time data collection, big data, and customer experience analytics, we deliver business intelligence for organizations of all sizes.

Our client success stories feature a range of clients from Fortune 500 companies to fast-growing startups. PMR’s collaborative environment is committed to building industry-specific solutions by transforming data from multiple streams into a strategic asset.

Contact us:

305 Broadway, 7th Floor
New York City, NY 10007
United States
Ph.no. +1-646-568-7751
E-mail id-sales@persistencemarketresearch.com
Website:https://www.persistencemarketresearch.com